Immunotherapy Talks with ACIR

Send us a text

Introducing "Immunotherapy Talks".
Reading research can be complicated — but it doesn’t have to be. In this podcast, ACIR digests the latest in cancer immunotherapy research into bite size pieces to help you stay on top the field.

Support the show

Thanks for listening! Let’s stay in touch:

• Tweet us at @ImmunoTalks
• Share our episodes on LinkedIN and Instagram
• Email us at [email protected]

Send us a text

In this 2nd episode, our co-hosts discuss the use of a macro-scale material to co-deliver GMCSF and CpG, both APC stimulating agents, as well as AML antigens to kill AML cells.
GUEST: Alex Najibi is now a postdoctoral fellow at Harvard School of Engineering and Applied Sciences, studying bioengineering in David Mooney's lab.
Original study => https://pubmed.ncbi.nlm.nih.gov/31937942/

Support the show

Thanks for listening! Let’s stay in touch:

• Tweet us at @ImmunoTalks
• Share our episodes on LinkedIN and Instagram
• Email us at [email protected]

Send us a text

In this first episode, our co-hosts talk about their background in immunology and what led them to it.
GUEST: Ed Fritsch. PhD, presidential fellow at the Dana-Farber, co-author of "Molecular Cloning: A Laboratory Manual", and co-founder of ACIR.

Support the show

Thanks for listening! Let’s stay in touch:

• Tweet us at @ImmunoTalks
• Share our episodes on LinkedIN and Instagram
• Email us at [email protected]